Gluten Technology and Education for Celiac Health (NCT06059716)
🩺 Plain-English Summary (8th-Grade Level)
The investigators propose to plan for a multi-center randomized controlled trial (M-RCT) to test the effectiveness of novel gluten detection technologies as an adjunct to telemedicine to manage celiac disease in newly diagnosed adults. If successful, the proposed intervention will improve mucosal recovery, promote a shift in current practice of celiac disease management toward long-term monitoring, and represent a significant step toward reducing the severe physical and psychological consequences of celiac disease.
Who can join: Review the eligibility criteria below.
Location: University of Chicago Medical Center — Chicago, Illinois
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
- Gluten detection technology (BEHAVIORAL)
- Continuous telemedicine monitoring (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- University of Chicago Medical Center — Chicago, Illinois
- Beth Israel Deaconess Medical Center — Boston, Massachusetts
- Columbia University Irving Medical Center — New York, New York
- Vanderbilt University Medical Center — Nashville, Tennessee
📞 Contact the Study Coordinator
Phone: (212) 305-9338
Email: BL114@cumc.columbia.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Celiac Disease
- A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease — Murrieta, California
- A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease — Stanford, California
- Immune Responses to Gluten — Aurora, Colorado
- Tissue Destruction and Healing in Celiac Disease — Pasadena, California
- Study of DONQ52 in Active Celiac Disease — Anniston, Alabama
Explore by condition: All Celiac Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.